Reklāma

PMCB Forex ziņas

PharmaCyte Names Joshua Silverman Interim CEO As CEO Kenneth Waggoner Steps Down

Biotechnology company PharmaCyte Biotech, Inc. (PMCB) announced Friday that its CEO Kenneth Waggoner has stepped down from the position as CEO, effective October 6, 2022. The Board has since appointed Joshua Silverman, a member of the Board, as interim CEO.

RTTNews | 989 days ago

Noteikumi | Privātums | Lapas karte | Site Map Calendar

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.

EURUSD	1.15021	GBPUSD	1.34372	AUDUSD	0.64462
USDJPY	146.22	USDCAD	1.37394	USDCHF	0.81767